The U.S. office-based labs market is projected to value USD 18.3 billion by 2030, registering a compound annual growth rate (CAGR) of 7.46% from 2022 to 2030. The U.S. office-based labs market is driven by the rising cases of cardiovascular diseases, particularly Peripheral Artery Diseases (PADs) among the geriatric population. A large number of patients in the U.S. opt for outpatient appointments, which is fueling the growth of office-based labs (OBL).
Susan Robbins
Vff88 Bet
Recipepalette26
Hargatoto Situs Slot
Zh Plumbing And Water Heaters
Sunwin Tải Game Bài Đổi Thưởng
Tv Ora Online
Oeg Outsourcing
98win
Heritage Countertops